Olanzapine-associated seizure

1. Hedges DW , Jeppson KG . New-onset seizure associated with quetiapine and olanzapine. Ann Pharmacother 2002; 36: 437–9.

2. Barr AN , Fischer JH , Koller WC , Spunt AL , Singhal A. Serum haloperidol concentration and choreiform movements in Huntington's disease. Neurology 1988; 38: 84–8.

3. Dipple HC . The use of olanzapine for movement disorder in Huntington's disease: a first case report (letter). J Neurol Neurosurg Psychiatry 1999; 67: 123–4.

4. Grove VE Jr , Quintanilla J , DeVaney GT . Improvement of Huntington's disease with olanzapine and valproate. N Engl J Med 2000; 343: 973–4.

5. Naranjo CA , Busto U , Sellers EM , Sandor P , Ruiz I , Roberts EA , et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239–45.

6. Quarrell O , Harper P. The clinical neurology of Huntington's disease. In: Harper P , ed. Huntington's disease. London: WB Saunders, 1996: 359–94.

7. Pillmann F , Schlote K , Broich K , Marneros A. Electroencephalogram alterations during treatment with olanzapine. Psychopharmacology (Berl) 2000; 150: 216–9.